Louis Navellier’s #1 Stock for 2022

On October 20, the man who recommended Google before anyone else will reveal his #1 stock pick for 2022 — for FREE — ticker symbol and all — in a special presentation.

Wed, October 20 at 4:00PM ET
 
 
 
 

3 Biotechnology Stocks to Buy Now

This week, 3 Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).

China Biologic Products, Inc. (CBPO) is seeing ratings go up from a C last week to a B this week. China Biologic Products, Inc. is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. The company also gets A’s in sales growth and return on equity. For more information, get Portfolio Grader’s complete analysis of CBPO stock.

Ironwood Pharmaceuticals, Inc. Class A (IRWD) boosts its rating from a C to a B this week. Ironwood Pharmaceuticals, Inc. Class A discovers, develops, manufactures, and commercializes marketed drugs. The company also gets A’s in sales growth and earnings surprise. For more information, get Portfolio Grader’s complete analysis of IRWD stock.

Galena Biopharma, Inc.’s (GALE) ratings are looking better this week, moving up to a B from last week’s C. Galena Biopharma, Inc. is a biopharmaceuticals company that develops late-stage oncology drugs. For more information, get Portfolio Grader’s complete analysis of GALE stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/06/3-biotechnology-stocks-to-buy-now-5/.

©2021 InvestorPlace Media, LLC